SWM
DRIO icon

Sugarloaf Wealth Management’s DarioHealth DRIO Stock Holding History

Sugarloaf Wealth Management’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8
Closed -$3 – 764
2021
Q1 		$3 Buy
+8
New +$3.6K ﹤0.01% 629

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CHM
Collaborative Holdings Management New York $49.2M AUM 119.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sugarloaf Wealth Management's DRIO Position: Q2 2021 in Review

Sugarloaf Wealth Management sold out of DarioHealth (DRIO) in Q2 2021, closing a stake of 8 shares — an estimated $3 sold.

Sugarloaf Wealth Management first reported a position in DRIO in Q1 2021 and held it in 1 quarter. The position peaked at $3 in Q1 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2021.

  • Sugarloaf Wealth Management reported no remaining DarioHealth position as of Q2 2021 after selling out during the quarter.
  • Sugarloaf Wealth Management sold 8 DarioHealth shares in Q2 2021, an estimated $3.
  • Sugarloaf Wealth Management first reported a position in DarioHealth in Q1 2021 and held it in 1 quarter.
  • Sugarloaf Wealth Management's DarioHealth position peaked at $3 in Q1 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2021.

Based on Sugarloaf Wealth Management's 13F filing for Q2 2021, filed 20 Jul 2021.